Expression of SR-PSOX, a Novel Cell-Surface Scavenger Receptor for Phosphatidylserine and Oxidized LDL in Human Atherosclerotic Lesions

Receptor-mediated endocytosis of oxidized low density lipoprotein (Ox-LDL) by macrophages and the subsequent foam cell transformation in the arterial intima are key events in early atherogenesis. Recently, we have identified a novel macrophage cell-surface receptor for Ox-LDL by expression cloning from a cDNA library of phorbol 12-myristate 13-acetate–stimulated THP-1 cells, designated as the scavenger receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX). Here, we examined SR-PSOX expression in human atherosclerotic lesions. Total cellular RNA and fresh frozen sections were prepared from human carotid endarterectomy specimens (from 21 patients) and directional coronary atherectomy specimens (from 11 patients). Fragments of human aortas of 2 patients without visible atherosclerotic lesions served as negative controls. Quantitative reverse transcription–polymerase chain reaction demonstrated that SR-PSOX mRNA expression was prominent in atherosclerotic lesions but undetectable in normal aortas. Immunohistochemistry showed that SR-PSOX was predominantly expressed by lipid-laden macrophages in the intima of atherosclerotic plaques in carotid endarterectomy and directional coronary atherectomy specimens, although its expression was not detectable in normal arterial wall. Double-labeled immunohistochemistry confirmed that SR-PSOX is expressed by intimal macrophages. Taken together, SR-PSOX may be involved in Ox-LDL uptake and subsequent foam cell transformation in macrophages in vivo and thus may play important roles in human atherosclerotic lesion formation.

[1]  M. Freeman,et al.  Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II , 1990, Nature.

[2]  D. Soler,et al.  Expression Cloning of the STRL33/BONZO/TYMSTR Ligand Reveals Elements of CC, CXC, and CX3C Chemokines , 2001, The Journal of Immunology.

[3]  T. Kodama,et al.  Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. , 1992, The American journal of pathology.

[4]  A. Gotto,et al.  Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. , 2000, The Journal of biological chemistry.

[5]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[6]  T. Kodama,et al.  Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. , 1995, European journal of biochemistry.

[7]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[8]  A. C. Nicholson,et al.  Inhibition of Macrophage Scavenger Receptor Activity by Tumor Necrosis Factor- Is Transcriptionally and Post-transcriptionally Regulated (*) , 1996, The Journal of Biological Chemistry.

[9]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[10]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[11]  S Gordon,et al.  Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Krieger,et al.  Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.

[13]  R. Evans,et al.  PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. , 1998, Cell.

[14]  H. Lodish,et al.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.

[15]  T. Kita,et al.  Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Kita,et al.  Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. , 1998, Circulation research.

[17]  D. Steinberg,et al.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. , 1991, The Journal of clinical investigation.

[18]  M. Gimbrone,et al.  Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. , 1994, The Journal of clinical investigation.

[19]  M. Cybulsky,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.

[20]  M. Bruzelius,et al.  Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[21]  T. Kita,et al.  Transforming Growth Factor-β1 Increases the Expression of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 , 2000 .

[22]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[23]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[24]  R. Evans,et al.  PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.

[25]  S. Horiuchi,et al.  CD36, a Member of Class B Scavenger Receptor Family, Is a Receptor for Advanced Glycation End Products , 2001, Annals of the New York Academy of Sciences.

[26]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[27]  T. Kita,et al.  Molecular Cloning of a Novel Scavenger Receptor for Oxidized Low Density Lipoprotein, SR-PSOX, on Macrophages* , 2000, The Journal of Biological Chemistry.

[28]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[29]  D. Altshuler,et al.  The role of PPAR-γ in macrophage differentiation and cholesterol uptake , 2001, Nature Medicine.

[30]  T. Sawamura,et al.  and Gram-Negative Bacteria LOX-1 Supports Adhesion of Gram-Positive , 2001 .

[31]  S. Ryeom,et al.  CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. , 1996, Journal of cell science.

[32]  S Gordon,et al.  Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[33]  S. Horiuchi,et al.  Are advanced glycation end-products associated with amyloidosis in Alzheimer’s disease? , 1995, Neuroreport.

[34]  S. Gordon,et al.  Macrophage Class A Scavenger Receptor-Mediated Phagocytosis of Escherichia coli: Role of Cell Heterogeneity, Microbial Strain, and Culture Conditions In Vitro , 2000, Infection and Immunity.

[35]  D. Steinberg,et al.  The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Freeman,et al.  Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. , 1990, Nature.

[37]  S. Miyamoto,et al.  Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. , 1999, Circulation.

[38]  R. Assoian,et al.  Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. , 1991, The Journal of biological chemistry.

[39]  Hiroyuki Arai,et al.  CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products* , 2001, The Journal of Biological Chemistry.

[40]  M. Freeman,et al.  Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils , 1990, Nature.

[41]  D. Altshuler,et al.  The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. , 2001, Nature medicine.

[42]  K. Matsumoto,et al.  CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[43]  A. Gotto,et al.  Transforming Growth Factor-β1 (TGF-β1) and TGF-β2 Decrease Expression of CD36, the Type B Scavenger Receptor, through Mitogen-activated Protein Kinase Phosphorylation of Peroxisome Proliferator-activated Receptor-γ* , 2000, The Journal of Biological Chemistry.